G rowth failure among infants with hypoplastic left heart syndrome is common. 1, 2 We previously used the database from the National Heart, Lung, and Blood Institute-sponsored Pediatric Heart Network Single Ventricle Reconstruction (SVR) trial to assess growth patterns in the first 3 years after the Norwood procedure. 3 Because the factors contributing to impaired growth may change over time, particularly after the Fontan procedure, we sought to expand this analysis.
Methods
Neonates with hypoplastic left heart syndrome or a related single morphologic right ventricular anomaly were randomized to either a modified Blalock-Taussig shunt or right ventricle-to-pulmonary artery shunt in the SVR trial and followup was subsequently extended to 6 years of age. 4 Sociodemographic and clinical characteristics, medical and surgical variables, unanticipated procedures, complications, outcome data, and core laboratory analysis of echocardiographic images were collected. 3, 4 We extended our analysis of changes in z-scores-for-age for weight (WAZ), height (HAZ), and body mass index (BMIZ) using all available data ( Table I and Table II ; available at www.jpeds.com) on subjects from birth to 6 years of age. To assess the effect of the Fontan procedure, we analyzed measurements obtained between the pre-Fontan visit and 6 years of age. We included growth data up to death (n = 153), transplantation (n = 21), or biventricular repair (n = 3). The shunt type in place when the subject left the operating room after the Norwood procedure was used for this analysis.
The primary outcomes were the change in WAZ, HAZ, and BMIZ between birth and 6 years of age. Anthropometric measurements were obtained at study visits as previously described. 3 Reliable height data were available only at birth, pre-Fontan, and annually from 3-6 years of age.
Analyses were performed between birth and 6 years of age and between pre-Fontan and 6 years of age with subgroup analyses for those subjects with WAZ < −2 at Norwood discharge. A 1-sample t test was used to determine if the mean z-score for a growth of the study population differed from a z-score of 0 for the normative population. Simple linear regression was used to obtain initial estimates of association of each candidate predictor with change in WAZ, HAZ, and BMIZ. Nonlinear relationships with continuous outcomes were assessed by categorizing continuous variables into groups based on quartiles; in addition, relationships between the natural logarithm of predictors with skewed distributions and the outcomes were explored. Variables with unadjusted P < .20 were used as candidate predictors for multivariable modeling. For variables with >5% missing data, mean imputation was performed before conducting multivariable modeling. Stepwise linear regression was employed to develop multivariable models, in conjunction with bootstrapping (1000 samples) to obtain reliability estimates. The criteria to enter and remain in the model were P < .15 and P < .05, respectively. All terms in the final multivariable models have a reliability >50% and P < .05. Separate models were constructed adjusting, and not adjusting, for center.
Results

Birth to 6 Years of Age
The analysis of anthropometric measurements at 6 years of age included 265 subjects enrolled between May 2005 and July 2008 (Figure 1 ; available at www.jpeds.com). At 6 years of age, 19 SVR transplant-free survivors had not undergone the Fontan procedure. Mean WAZ (−0.58 ± 1.13) and mean HAZ (−1.03 ± 1.18) were below the mean of the normative population (P < .001 for both). WAZ was less impaired than HAZ (P < .001). By 6 years of age, 37% of subjects had WAZ < −1 and 51% had HAZ < −1; WAZ was < −2 in 9% and HAZ was < −2 in 18%. Mean BMIZ (0.09 ± 1.11) was similar to the normative population (P = .17) with 13% of subjects having BMIZ < −1 and 3% with BMIZ < −2.
Mean WAZ and mean HAZ decreased between birth and 6 years of age (P < .001 for both) ( Table III ; available at www.jpeds.com). WAZ decreased by ≥0.5 SD in 49% of subjects and HAZ decreased by ≥0.5 SD in 61%. In contrast with WAZ and HAZ, mean BMIZ increased between birth and 6 years of age. During this time, BMIZ decreased by ≥0.5 SD in 28% of subjects and increased by ≥0.5 SD in 52%. At 6 years of age, 9% of SVR survivors had BMIZ > 1.5 and 4% had BMIZ > 2.
The univariable results for candidate predictors that remained significant in any of the final multivariable models presented (both reliability >50% and P < .05) are shown in Table  IV (available at www.jpeds.com). Higher birth weight (P < .001), longer cumulative length of stay (LOS) for all admissions (P = .001), and being white/non-Hispanic (P = .02) were associated independently with a greater decrease in WAZ ( Table  V) . Higher birth weight was the only factor independently associated with a greater decrease in HAZ (P < .001). Males had a greater increase in BMIZ over the 6-year study period. A Hollingshead score of >54.5 (highest socioeconomic status) was associated with the smallest increase in BMIZ, but the relationship was not linear. Tube feeding at any time point correlated with a greater decrease in BMIZ. Independent predictors were similar whether or not center was included in the model and explained only 11% of the variation in change in BMIZ. Shunt type was not associated with change in WAZ, HAZ, or BMIZ.
Relation of the Fontan Procedure to Anthropometric Measurements at 6 Years of Age
Among the 255 subjects who had a Fontan procedure (33.8 ± 9.6 months of age), 1 subject underwent cardiac transplantation and 12 subjects died before 6 years of age. At the pre-Fontan visit, the mean WAZ (−0.51 ± 0.97) and HAZ (−0.96 ± 1.19) were significantly below the normative mean (P < .001). The WAZ was <−1 in 31% of subjects and <−2 in 5%. The mean WAZ decreased between the pre-Fontan visit and 6 years of age (Table III) , but compared with the Norwood and stage II procedures, 3 the Fontan procedure had the least impact on WAZ (Figure 2 ). During this time interval, WAZ decreased by ≥0.5 SD in 24% of subjects.
The HAZ was <−1 in 50% and <−2 in 15% at the preFontan assessment. Similar to WAZ, HAZ decreased from the pre-Fontan visit to 6 years of age (Table III) with a decrease of ≥0.5 SD in 26% of subjects. In contrast with the WAZ and HAZ, at the pre-Fontan visit, the mean BMIZ was similar to the normative population; 16% were <−1 and 2% were <-2. Overall, the mean BMIZ increased between Fontan and 6 years of age. During this time, 29% of subjects had a decrease in BMIZ of ≥0.5 SD and 28% had an increase of ≥0.5 SD.
Center was associated independently with change in WAZ (P = .03). With center removed from the model, being white/ non-Hispanic was associated independently with a decrease in WAZ. Greater LOS at the stage II hospitalization but shorter cumulative LOS at all hospitalizations correlated with a greater increase in WAZ. Being fed a caloric-supplemented diet at any time point was the only variable associated with a greater decrease in HAZ. Center was associated with change in BMIZ from pre-Fontan to 6 years of age, but explained only 14% of the variation. The mean change in BMIZ ranged from a decrease of 0.94 SD to an increase of 0.88 SD (P = .002). The type of shunt in place after the Norwood procedure had no association with change in any anthropometric measurement.
Anthropometric Measurements at 6 Years of Age for Subjects with WAZ <−2 at Norwood Discharge
Of the 445 subjects discharged from the Norwood hospitalization, 169 (38%) had WAZ < −2. The prevalence of WAZ < −2 was similar between the group of subjects who died or were transplanted (35/97, 36%) and the group who survived (134/ 348, 39%; P = .72). At 6 years of age, WAZ for these subjects was lower than the group discharged with WAZ ≥ -2 (-1.08 ± 1.01 vs −0.24 ± 1.08; P < .001). Right ventricular area change at the pre-Norwood echocardiogram had a nonlinear association with increased weight gain between Norwood discharge and 6 years of age. Multiple births and low birth weight were also associated independently with better weight gain between Norwood and 6 years of age in this subgroup. Between the Fontan and 6 years of age, being black non-Hispanic and oral feeding at 13-24 months of age were associated with better weight gain. At 6 years of age, HAZ was similar between those discharged with and those without WAZ < -2 (P = .25). BMIZ was 0.26 SD below normal in those discharged with WAZ < -2 and 0.34 SD above normal in those with WAZ ≥ −2 (P < .001). Of those discharged with WAZ < −2, BMIZ was >1.5 in 5% and none had BMIZ > 2.0 at 6 years of age.
Discussion
This longitudinal assessment of growth from birth to 6 years of age in a well-characterized cohort of subjects with hypoplastic left heart syndrome and related single right ventricular anomalies enrolled in the SVR trial demonstrated that the Fontan procedure had little effect on growth at 6 years of age. Similar to our findings at 3 years of age, 3 both mean WAZ and HAZ for this study population remained below mean values for the normative population, with HAZ more impaired than WAZ at 6 years of age. Despite the drop in both mean WAZ and HAZ, mean BMIZ increased by >0.5 SD in >50% of the SVR survivors. These data highlight both the trends of the Norwood procedure and the variance in growth for survivors who are 6 years of age and transplant free.
It is possible that the increase in BMIZ may be from increasing adipose rather than increasing lean body mass. Because of the strong associations reported between poor weight gain in infancy and increased morbidity, including prolonged hospitalization, and impaired neurodevelopment, 5, 6 many centers have focused on improving weight gain by increasing caloric intake with varying degrees of success. 1, 2, 5 Increasing weight by adding adipose tissue without a proportional increase in height, however, may have long-term detrimental effects.
In this cohort, factors associated with better weight gain were inconsistent, varied by time interval and, at best, explained only a small percentage of the variability in growth over the first 6 years of life. A lesser total LOS for all hospitalizations correlated with a greater increase in growth between Fontan and 6 years of age likely reflecting better operative outcomes or less severe disease. Non-Hispanic black subjects had the greatest increase and higher birth weight resulted in a greater decline in growth between birth and 6 years of age. These findings are consistent with previous reports and have been thought to reflect a regression toward the mean. 3, 5 This explanation may be too simplistic, however, because HAZ remains more impaired than WAZ and no association was found between birth weight and BMIZ at 6 years of age.
Feeding predictor variables were not associated with growth. Tube feeding at any time was associated with a greater decrease in BMIZ between birth and 6 years of age. Being fed a caloricsupplemented diet at any time was associated with a greater decrease in HAZ between pre-Fontan and 6 years of age and may indicate that increasing calories alone has little effect on height in this population. Because caloric intake was not collected in the SVR database, however, these associations are difficult to interpret beyond noting that feeding seems more associated with change in BMIZ rather than change in WAZ or HAZ alone.
It is noteworthy that infants with WAZ < −2 at Norwood discharge experienced increases in WAZ indicating that even the smallest subjects were capable of gaining weight if they survived. Mean HAZ at 6 years of age was similar between the group with WAZ < −2 and the group with WAZ ≥ 2 at Norwood discharge.
Although previous reports documented short stature in older patients receiving Fontan, 3, 6 height has not been the focus of efforts to improve early growth historically. Height, not weight, has been associated with poorer socioeconomic and neurodevelopmental outcomes, however. 5, 7, 8 Impairment of linear growth is not readily modifiable by increasing caloric intake.
De novo mutations likely play a role in impairment of linear growth. 9 Genetic polymorphisms or pathologic copy number variants have been associated with short stature and worse THE JOURNAL OF PEDIATRICS • www.jpeds.com 
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neurodevelopmental outcomes in children with single ventricles, but the role of genetic factors is still being explored. 10 Disruption of the neuroendocrine growth axis, 11 and the longterm effects of an unfavorable fetal environment 8 are also being investigated.
This study has several limitations. Growth measurements were not standardized as outcome measurements in the SVR trial. These measurements were used for clinical care, however, and are obtained typically carefully in this vulnerable population. Because height is known to be unreliable in infants, 3 we included only birth length and height in older children. The anthropometric data are conditional on transplant-free survival to each respective time point, using all available data to maximize precision of our estimates. As a result, qualitative comparisons of the change in anthropometric measurements among the time intervals are based on diminishing cohort size and subject to survivor bias. Genotyping was not used to define genetic syndromes. Children with potentially pathogenic copy number variants or de novo mutations often have no obvious clinical findings, 9,10 potentially accounting for the failure to find an association between genetic syndrome and poor linear growth or weight gain in this study. Blood samples were stored for future genetic studies that may be enlightening.
Thus, at 6 years of age, height remained more impaired than weight for SVR survivors who are transplant free. Efforts to avoid excessive weight gain in these children warrant attention because they are particularly vulnerable to the morbidity associated with obesity. Future studies should consider the impact of other factors beyond caloric intake to improve height in this population. 
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274.e2 Table I . Candidate predictors considered in models predicting change in weight-for-age Z-score, height-for-age Z-score, and body mass index z-score for the designated time intervals Table II . Candidate predictors considered in models predicting change in weight-for-age Z-score, height-for-age Z-score, and body mass index z-score for the designated time intervals *Unless otherwise indicated, all mean values and SDs are based on the subjects with 6-year growth measurements and available data on the change from birth to 6 years of age. Continuous variables were categorized into groups based on the quartiles of the distribution using all available data. †Mean values and SDs are based on the subjects with 6-year growth measurements and available data on the change from pre-Fontan to 6 years of age.
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